Le Lézard
Classified in: Health
Subjects: CHI, PER, DEI

Centria Autism Welcomes Scott Bendler as Chief Operating Officer


Bendler brings over 17 years of operational healthcare experience to the role

FARMINGTON HILLS, Mich., Dec. 18, 2023 /PRNewswire/ -- Centria Autism, a national provider of Applied Behavior Analysis (ABA) therapy for children with autism, has named Scott Bendler as its new Chief Operating Officer (COO), effective November 13, 2023.

This role will see Bendler providing oversight to Centria's day-to-day operations. His expertise will support the agency in continuing to develop and improve processes, with a focus on increasing accessibility to services for clients.

"With his robust background in healthcare operations, Scott brings exactly the skillset and eye for efficiency Centria is looking for to bolster our commitment to organizational and clinical excellence," said David Harbour, Chief Executive Officer at Centria. "His experience and insights will translate into impactful support of our mission to continue trailblazing improved provision of autism care to our clients."

Bendler brings over 17 years of experience in healthcare to his new role. Following an 11-year operational stint with Epic Health Services, Inc., where he held two directorial positions, he most recently served as Vice President of Operations at Healthcare Associates of Texas. Bendler's achievements in this role include the successful development of a standardized staffing model that supported organizational growth while maintaining costs and enhancing patient care.

"The opportunity to work with and support special needs children was truly the determining factor in my pursuit of this role. Getting to advocate for this community that doesn't always have the voice they deserve in this world and helping them progress and achieve their goals is extremely rewarding," said Bendler. "Centria's commitment to clinical excellence is a driving force that I am honored to help build upon."

This addition to the team is the latest step in Centria's efforts to transform their operations to better serve clients and their families. Earlier this month, the agency announced a pioneering new organizational restructure geared at aligning clinical and operational teams, creating a synergy that promises to enhance both clinical outcomes and operational efficiency.

About Centria Autism

Centria Autism is a leading national provider of Applied Behavior Analysis (ABA) therapy for children with autism and their families. Headquartered in Farmington Hills, Michigan ? a suburb of Detroit ? Centria employs continuous efforts to advance the science of ABA and deliver high-quality support through their Foundations of Care model, centering clients and individualizing care through Practical Functional Assessment and Skills-Based Treatment (PFA-SBT). Centria aligns each client's unique aspirations with developmentally appropriate treatment goals to inform compassionate, trauma-informed care, respecting the dignity and value of each client served.

For further information, please visit www.centriahealthcare.com.

SOURCE Centria Autism


These press releases may also interest you

at 22:34
Cynata Therapeutics Limited , a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers (DFU). Key Highlights The trial met its primary...

at 21:44
BioArctic AB's (publ) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of early Alzheimer's disease (AD)1.   Leqembi...

at 20:20
dBio has joined the American Heart Association Center for Health Technology & Innovation (the Center) Innovators' Network, an initiative focused on building and fostering health technology relationships to develop innovative and scalable...

at 20:05
The Asian Entrepreneurship Award (AEA) Steering Committee is pleased to announce that AEA2024, the 13th annual innovation award event for fast-growing Asian startups, was held on November 20th and 21st. Taking place in-person for the first time in...

at 18:40
Roswell Park CEO Candace S. Johnson, PhD, introduces center's first Physician in Chief, leaders in strategic areas Michael Wong, MD, PhD, FRPC, joins Roswell Park from MD Anderson...

at 18:31
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta...



News published on and distributed by: